Monday, October 27, 2025
113 US-listed companies reporting
Symbol Company EPS Est. Revenue Est. Price Market Cap NUE Nucor Corporation $2.18 8.18B $236.87 53.95B Chart → FFIV F5, Inc. $3.97 794.86M $421.47 23.78B Chart → BRO Brown & Brown, Inc. $0.94 1.55B $66.86 22.66B Chart → CR Crane Company $1.49 578.89M $218.84 12.64B Chart → BRX Brixmor Property Group Inc. $0.23 338.89M $31.36 9.62B Chart → ARE Alexandria Real Estate Equities, Inc. $2.31 744.88M $48.70 8.49B Chart → PRK Park National Corporation $2.74 140.28M $186.06 3.37B Chart → AGYS Agilysys, Inc. $0.38 76.92M $106.51 3.00B Chart → NBTB NBT Bancorp Inc. $0.97 183.81M $51.30 2.67B Chart → EFSCP Enterprise Financial Services Corp $1.29 181.19M $20.70 2.44B Chart → EFSC Enterprise Financial Services Corp $1.29 181.19M $66.30 2.43B Chart → NWBI Northwest Bancshares, Inc. $0.30 165.96M $15.20 2.22B Chart → MBINM Merchants Bancorp $0.79 163.90M $25.44 2.21B Chart → GABC German American Bancorp, Inc. $0.86 92.96M $47.83 1.80B Chart → LKFN Lakeland Financial Corporation $1.04 69.15M $61.63 1.54B Chart → FSBC Five Star Bancorp $0.71 41.74M $48.37 1.03B Chart → FSUN FirstSun Capital Bancorp $0.90 106.73M $35.31 982.31M Chart → CBNK Capital Bancorp, Inc. $0.88 61.06M $35.50 578.23M Chart → BMRC Bank of Marin Bancorp $0.42 32.31M $28.40 459.79M Chart → BBBY Bed Bath & Beyond Inc. $-0.48 263.71M $5.35 398.54M Chart → LNKB LINKBANCORP, Inc. $0.21 29.99M $8.69 325.59M Chart → CZWI Citizens Community Bancorp, Inc. $0.37 16.30M $23.29 224.61M Chart → OVBC Ohio Valley Banc Corp. - - $43.70 205.87M Chart → BCBP BCB Bancorp, Inc. $0.21 25.22M $10.34 179.54M Chart → MNSB MainStreet Bancshares, Inc. $0.51 19.40M $24.18 172.10M Chart → MNSBP MainStreet Bancshares, Inc. $0.51 19.40M $25.33 171.71M Chart → BCTX BriaCell Therapeutics Corp. $-12.11 - $3.94 7.42M Chart → AIXI Xiao-I Corporation $-0.01 41.97M $1.76 930.60K Chart →
Show more on this date (13 left)
Data source: financialmodelingprep.com. Estimates can change before the report date — treat this as a starting point for further research, not investment advice.